Avella Newsroom

Avella EVP of Clinical and Quality Assurance, Eric Sredzinski, was recently quoted in the following Specialty Pharmacy Continuum article.

A perfect storm is brewing as specialty drug prices reach all-time highs, out-of-pocket drug costs increase and financial assistance programs reach capacity.

“While commercial and Medicare Part D patients are seeing rising cost-sharing requirements and greater demand for assistance, the increasing contributions from drug companies over the past five years seem to be plateauing,” Daniel Klein, the president and CEO of the Patient Access Network (PAN) Foundation, said during the Asembia 2018 Specialty Pharmacy Summit.

At Asembia Specialty Pharmacy Summit 2018, Kelly Mathews, PharmD, CSP, the director of clinical services and residency program director at Avella Specialty Pharmacy, discusses the paradigm shift in treating patients with inflammatory bowel disease with Christopher T. Owens, PharmD, MPH, the associate vice president, Kasiska Division of Health Sciences, Idaho State University. 

NCPDP announced today the Opening Keynote Panel for its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey, May 7-9, 2018, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. The Keynote Panel will address “Data Challenges and Opportunities to Improve the Patient Journey,” on Tuesday, May 8, 2018. Avella founder and chairman of the board, John Musil, will participate on the panel representing specialty pharmacy.

Avella was recently featured in Pharmaceutical Commerce article for its work in medication adherence and technology. 

Poor adherence to prescribed medications creates one of today’s most pressing public health issues. When patients fail to take their medications as prescribed — either stopping before the course of treatment is complete, abandoning long-term therapies prescribed for chronic conditions, or taking the medications incorrectly — it creates far-reaching clinical and financial consequences for all stakeholders:

Through emerging options that create automated processes to address prevention and wellness and increase accountability by the patient, specialty pharmacy has the ability to deliver greater value, said Eric Sredzinski, executive vice-president of clinical affairs and quality assurance with Avella Specialty Pharmacy.

Avella's Vice President of Ophthalmology, Jim Rehovsky, is featured in Specialty Pharmacy Continuum article titled, Diabetic Macular Edema: 6 Steps for Better Control.

If you haven’t already, we hope you’ll begin reading this 2-part series by viewing part 1, where we profile 5 women who we’ve identified among specialty pharmacy’s most highly-regarded leaders. In the conclusion to this series, you’ll meet another group of women who are applying their unique capabilities and expertise to positively impact their organizations, as well as the industry at large.

Avella CEO Rebecca Shanahan authors op-ed for The Hill

It’s no secret that in most households across America, women are the individuals making health care decisions for themselves and their families. A recent study from the Center for Talent Innovation, a New York-based think-tank, showed that of women who work and have children under 18 years old, 94 percent make health care decisions for others.

Often referred to as a family’s chief medical officer (or CMO), women have become the backbone of the $6 trillion health care industry — doing the bulk of the purchasing, scheduling and research around healthcare decisions.

Part B News recently talked to physicians and other experts about the opioid crisis and how practices should handle it. We also talked to a pharmacy expert and executive with some actionable ideas for managing patients on these powerful drugs.